Boom time: Rubius, Crinetics find big support in upsized IPOs totaling $343M raise
Thought Rubius Therapeutics was ambitious when it set terms for a $200 million IPO? Well, think again.
The Cambridge, MA-based biotech has just bagged …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
